NAFLD group (n = 62) | ALD group (n = 17) | ||||||
---|---|---|---|---|---|---|---|
Pre-treatment | Post-treatment | P value | Pre-treatment | Post-treatment | P value | ||
HbA1c (%) | 8.57 ± 1.23 | 7.99 ± 1.22 | <0.001 | HbA1c (%) | 8.29 ± 1.77 | 7.79 ± 1.42 | 0.099 |
AST (IU/L) | 52.7 ± 25.3 | 55.5 ± 29.4 | 0.491 | AST (IU/L) | 66.5 ± 28.3 | 63.1 ± 22.0 | 0.563 |
ALT (IU/L) | 79.2 ± 45.4 | 74.7 ± 41.5 | 0.398 | ALT (IU/L) | 88.0 ± 67.4 | 63.0 ± 26.1 | 0.083 |
γGT (IU/L) | 112.0 ± 80.4 | 115.4 ± 95.7 | 0.713 | γGT (IU/L) | 232.8 ± 144.7 | 163.8 ± 102.3 | 0.023 |